NeoGenomics, Inc. (NEO)
16.66
+0.46
(+2.84%)
USD |
NASDAQ |
Oct 13, 16:00
16.66
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Cash from Investing (Quarterly) : -8.319M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.319M |
| March 31, 2026 | -5.00M |
| December 31, 2025 | -6.305M |
| September 30, 2025 | -0.277M |
| June 30, 2025 | -9.314M |
| March 31, 2025 | 3.56M |
| December 31, 2024 | -5.467M |
| September 30, 2024 | -3.516M |
| June 30, 2024 | 7.313M |
| March 31, 2024 | 14.52M |
| December 31, 2023 | 17.20M |
| September 30, 2023 | 20.82M |
| June 30, 2023 | 14.95M |
| March 31, 2023 | 23.74M |
| December 31, 2022 | -1.063M |
| September 30, 2022 | -4.198M |
| June 30, 2022 | -6.274M |
| March 31, 2022 | 12.05M |
| December 31, 2021 | -9.583M |
| September 30, 2021 | -14.69M |
| June 30, 2021 | -453.41M |
| March 31, 2021 | -154.69M |
| December 31, 2020 | -28.85M |
| September 30, 2020 | -70.72M |
| June 30, 2020 | -18.16M |
| Date | Value |
|---|---|
| March 31, 2020 | -41.71M |
| December 31, 2019 | -6.076M |
| September 30, 2019 | -7.316M |
| June 30, 2019 | -3.042M |
| March 31, 2019 | -3.196M |
| December 31, 2018 | -128.60M |
| September 30, 2018 | -2.148M |
| June 30, 2018 | -4.277M |
| March 31, 2018 | -4.666M |
| December 31, 2017 | -3.523M |
| September 30, 2017 | -2.303M |
| June 30, 2017 | -4.857M |
| March 31, 2017 | -3.007M |
| December 31, 2016 | -1.173M |
| September 30, 2016 | -1.903M |
| June 30, 2016 | -2.424M |
| March 31, 2016 | -1.001M |
| December 31, 2015 | -73.47M |
| September 30, 2015 | -0.502M |
| June 30, 2015 | -0.338M |
| March 31, 2015 | -0.842M |
| December 31, 2014 | -1.054M |
| September 30, 2014 | -6.582M |
| June 30, 2014 | -1.083M |
| March 31, 2014 | -0.883M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Precipio, Inc. | -0.132M |
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| OPKO Health, Inc. | 15.54M |
| Psychemedics Corp. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 19.96M |
| Cash from Financing (Quarterly) | -12.24M |
| Free Cash Flow | -7.355M |
| Free Cash Flow Per Share (Quarterly) | 0.0897 |
| Free Cash Flow to Equity (Quarterly) | -28.10M |
| Free Cash Flow to Firm (Quarterly) | 12.70M |
| Free Cash Flow Yield | -0.34% |